ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug targets advanced prostate cancer in first human trial
Disease control OngoingThis early-stage study is testing a new radioactive antibody drug called JNJ-69086420 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The main goal is to find the safest and most effective dose by monitoring side effect…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug duo tested in fight against tough pancreatic cancer
Disease control OngoingThis is a small, early-stage study to see if a combination of two drugs, pembrolizumab and lenvatinib, can help control advanced pancreatic cancer that has worsened after initial treatment. The study will enroll about 15 patients to check if the treatment shrinks tumors and is sa…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
GPS for needles: new tech aims to pinpoint Hard-to-Find tumors
Diagnosis ENROLLING_BY_INVITATIONThis study is testing a new tracking system that works like a mini-GPS inside a needle. It aims to help doctors more accurately guide needles to hard-to-find tumors during biopsy or ablation procedures, using a weak magnetic field. The research will see if this 'smart needle' can…
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
Cancer patients monitored for 15 years after groundbreaking gene treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows patients for up to 15 years after they received experimental gene therapies for cancers like melanoma and neuroendocrine tumors. The goal is to monitor long-term safety and health outcomes, as required by the FDA. Participants will have regular check-ups, blood…
Matched conditions: ADENOCARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC